SCHEMBL14083496

SCHEMBL14083496

O=C(Nc1ccccc1CCO)c1ccc(-c2ncccc2Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 8/20 0.55
▸ HDAC1 Q13547 2/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TRPV4 Q9HBA0 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ KDR P35968 1/20 0.44
▸ SCN5A Q14524 2/20 0.43
▸ SCN9A Q15858 2/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ EIF4H Q15056 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ SLC16A3 O15427 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083477 0.90 TRPV1 (0.56) TRPV1HDAC1NPC1RAB9AMEN1
SCHEMBL14083940 0.88 HIF1A (0.51) TRPV1KDRSCN5ASCN9ASLC16A3
SCHEMBL14083478 0.85 TRPV1 (0.64) TRPV1HDAC1NPC1RAB9AMEN1
SCHEMBL14083603 0.83 TRPV1 (0.46) TRPV1MEN1KMT2AKDRSCN5A
SCHEMBL14083666 0.83 NPC1 (0.44) TRPV1HDAC1NPC1RAB9AMAPT
SCHEMBL14083473 0.82 TRPV1 (0.60) TRPV1HDAC1NPC1RAB9AMEN1
SCHEMBL3618243 0.82 TRPV1 (0.60) TRPV1HDAC1NPC1RAB9AMEN1
SCHEMBL14083508 0.82 RAB9A (0.70) TRPV1HDAC1NPC1RAB9AMEN1
SCHEMBL14083761 0.81 POLB (0.54) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL14082255 0.81 TRPV1 (0.53) TRPV1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885HDAC1 556/4885NPC1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback